LUNDBECK LLC for LUNDBECK LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 17, 2012 | $80,000 | Replaced |
| 3rd Quarter - Amendment | Jan 19, 2013 | $180,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Monitored issues related to the implementation of the Patient Protection and Affordable Care Act (P.L. 111-148), legislation related to expansion of the 340B Program, coverage of orphan drugs and S.3187, Food and Drug Administration Safety and Innovation Act (PDUFA reauthorization).
Foreign entity interest: Ensuring continued patient access to Orphan and Rare Disease medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATROSKI LAWSON New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.